A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origin

Mise à jour : Il y a 5 ans
Référence : ISRCTN63374575

Extrait

Not provided at time of registration


Critère d'inclusion

  • Carcinoma of unknown primary origin

Liens